Prediction model | Validation (using derivation or external dataset) | Dataset used, country | AUC (95% CI) | Source |
---|---|---|---|---|
Colorectal cancer | ||||
 Bristol-Birmingham equation [29] | Derivation | THIN, UK | 0.83 (0.82, 0.84) | [29] |
 | External | CAPER, UK | 0.92 (0.91, 0.94) | [29] |
 | External | CEDAR, Netherlands | 0.84 (0.77, 0.90) | [27] |
 Netherlands model [28] | Derivation | Primary care, Netherlands | 0.97 | [28] |
 | External | Secondary care, UK | 0.78 (0.74, 0.81) | [40] |
 | External | CEDAR, Netherlands | 0.72 (0.62, 0.81) | [27] |
 Netherlands model including polyps [28] | Derivation | Primary care, Netherlands | 0.92 | [28] |
 Qcancer (male) [22] | Derivation | Qresearch, UK | 0.91 (0. 09, 0.91) | [22] |
 | External | THIN (multiple imputation), UK | 0.92 (0.91, 0.92) | [23] |
 |  | THIN (complete case analysis), UK | 0.90 (0.89, 0.91) | [23] |
 Qcancer (female) [22] | Derivation | Qresearch, UK | 0.89 (0.88, 0.90) | [22] |
 | External | THIN (complete case analysis), UK | 0.91 (0.90, 0.92) | [23] |
 Danish model [31] | External | CEDAR, Netherlands | 0.6 (0.48, 0.72) | [27] |
 RAT (2005) [33] | External | CEDAR, Netherlands | 0.81 (0.75, 0.88) | [27] |
Multiple cancer sites | ||||
 Muris abdominal complaints model [30] | External | CEDAR, Netherlands | 0.62 (0.54, 0.70) | [27] |